Immogen Bio
CD4see:
Digital Control of Cancer Immunity
Immogen Bio uses the power of the immune system to target brain tumors. Our patented technology. called CD4see, mobilizes CD4+ T cells to hunt down and destroy glioblastoma tumor cells. Immogen Bio is a privately held preclincal stage company based in California.
We welcome your inquiries: